Grass pollen

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
V01AA02 Grass pollen V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts
Discover more medicines within V01AA02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ORALAIR Tablets FDA, National Drug Code (US) MPI, US: SPL/PLR

External identifiers

SNOMED-CT Concept: 256277009
Grass pollen (substance)

Medicines

Grass pollen is an active ingredient of these brands:

Austria (AT)

Canada (CA)

Croatia (HR)

Estonia (EE)

Finland (FI)

  • GRAZAX as Grass pollen extract (Phleum pratense)

France (FR)

Ireland (IE)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Spain (ES)

Tunisia (TN)

Turkey (TR)

  • GRAZAX as Grass pollen extract (Phleum pratense)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.